The prognosis from a CPG4 cancer is considered poor if left untreated. Treatment is recommended to reduce the risk that the cancer may spread (metastasis) or cause death.
The National Institute for Health and Care Excellence currently recommends that men diagnosed with CPG4 cancer are offered treatment with the intention of cure.
Active surveillance is not recommended. It may be, however, that you have very significant other medical conditions that will limit your normal life expectancy and treatment for prostate cancer may do you more harm than good. In this case, your doctor will discuss this with you and determine the best option for you.
Based on the NICE recommendations you are likely to be offered:
Based on the NICE recommendations you may be asked to consider:
